HighPoint Advisor Group’s Halozyme HALO Stock Holding History

HighPoint Advisor Group’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,945	Closed	-$265K	–	821
2025 Q4	$265K	Sell	3,945 -103	-3%	-$6.93K	0.01%	906
2025 Q3	$297K	Sell	4,048 -1,015	-20%	-$67.4K	0.01%	540
2025 Q2	$263K	Buy	5,063 +40	+0.8%	+$2.28K	0.01%	564
2025 Q1	$305K	Sell	5,023 -959	-16%	-$55.7K	0.02%	479
2024 Q4	$343K	Buy	5,982 +38	+0.6%	+$1.95K	0.02%	464
2024 Q3	$340K	Buy	+5,944	New	+$341K	0.02%	451

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HighPoint Advisor Group's HALO Position: Q1 2026 in Review

HighPoint Advisor Group sold out of Halozyme (HALO) in Q1 2026, closing a stake of 3,945 shares — an estimated $265K sold.

HighPoint Advisor Group first reported a position in HALO in Q3 2024 and held it in 6 quarters. The position peaked at $343K in Q4 2024. 636 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

HighPoint Advisor Group reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
HighPoint Advisor Group sold 3,945 Halozyme shares in Q1 2026, an estimated $265K.
HighPoint Advisor Group first reported a position in Halozyme in Q3 2024 and held it in 6 quarters.
HighPoint Advisor Group's Halozyme position peaked at $343K in Q4 2024.
636 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on HighPoint Advisor Group's 13F filing for Q1 2026, filed 14 May 2026.